Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04162847 · ClinicalTrials.gov registry record · NA

Harnessing Mobile Technology to Reduce Mental Health Disorders in College Populations

A NA study of Anxiety Disorders and Depressive Disorder, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
6,205
Enrollment target
4
Study locations

NCT04162847 is a NA study of Anxiety Disorders and Depressive Disorder that has completed, run by Washington University School of Medicine. The registered enrollment target is 6,205 participants, above the 1,066-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (482% higher). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04162847, a NA study of Anxiety Disorders and Depressive Disorder, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
6,205 participants
Enrollment target
4
Study locations

Study Summary

The prevalence of mental health problems among college populations has risen steadily in recent decades, with one third of today's students struggling with anxiety, depression, or an eating disorder (ED). Yet, only 20-40% of college students with mental disorders receive treatment. Inadequacies in mental health care delivery result in prolonged illness, disease progression, poorer prognosis, and greater likelihood of relapse, highlighting the need for a new approach for detecting mental health problems and engaging college students in services. The investigators have developed a transdiagnostic, low-cost mobile health targeted prevention and intervention platform that uses population-level screening for engaging college students in tailored services that address common mental health problems. This care delivery system represents an ideal model given its use of evidence-based mobile programs, a transdiagnostic approach that addresses comorbid mental health issues, and personalized screening and intervention to increase service uptake, enhance engagement, and improve outcomes. Further, this service delivery model harnesses the expertise of an interdisciplinary team of behavioral scientists, college student mental health scholars, technology researchers, and health economists. This work bridges the study team's collective leadership over the past 25 years in successfully implementing a population-based screening program in more than 160 colleges and demonstrating the effectiveness of Internet-based programs for targeted prevention and intervention for anxiety, depression, and EDs. Through this study, Investigators will test the impact of this mobile mental health platform for service delivery in a large-scale trial across a diverse range of U.S. colleges. Students who screen positive or at high-risk for clinical anxiety, depression, or EDs (excluding anorexia nervosa, for which more intensive medical monitoring is warranted) and who are not currently engaged in mental

Interventions

  • DEVICE SilverCloud Health Intervention

Study Locations (4)

California

  • Palo Alto University - Palo Alto

Michigan

  • University of Michigan - Ann Arbor

Missouri

  • Washington University School of Medicine - St Louis

Pennsylvania

  • Pennsylvania State University - State College

Trial Details

FieldValue
Enrollment Target 6,205 participants
Start Date 2019-10-07
Est. Completion 2023-12-31
Phase NA

What the Registry Record Tells You About NCT04162847

The ClinicalTrials.gov registry entry for NCT04162847 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6,205 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,066-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (482% higher). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Anxiety Disorders appearing as the primary indexed condition, and to 1 intervention - of which SilverCloud Health Intervention is the first listed.

NCT04162847 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Michigan, Missouri.

Frequently Asked Questions

What is clinical trial NCT04162847 about?

NCT04162847 is a clinical study titled "Harnessing Mobile Technology to Reduce Mental Health Disorders in College Populations". The prevalence of mental health problems among college populations has risen steadily in recent decades, with one third of today's students struggling with anxiety, depression, or an eating disorder (ED). Yet, only 20-40% of college students with mental disorders receive treatment. Inadequacies in m...

What is the current status of trial NCT04162847?

This trial is currently completed. It is a NA study. The enrollment target is 6,205 participants. The study started on 2019-10-07. Estimated completion is 2023-12-31.

What conditions does trial NCT04162847 study?

This clinical trial studies the following conditions: Anxiety Disorders, Depressive Disorder, Eating Disorders.

What interventions are being tested in trial NCT04162847?

The interventions under investigation include: SilverCloud Health Intervention (DEVICE).

Who is sponsoring clinical trial NCT04162847?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04162847 being conducted?

This trial has 4 study locations across California, Michigan, Missouri, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.